• Employees
  • About us
    • Mandate and owners
    • Strategy and goals
    • Our funding
    • Our competence
    • Board of Directors
    • Summary of the year
  • News
  • Norwegian Bokmål
Inven2 logo hvit
  • Innovation
    • About innovation
    • Information to researchers
    • Information to investors
    • Information to industry
    • The Innovation Award
  • Clinical studies
    • About clinical trials
    • Information to industry
    • Information to study personnel
  • Licensing opportunities
Inven2 logo
  • Employees
  • About us
    • Mandate and owners
    • Strategy and goals
    • Our funding
    • Our competence
    • Board of Directors
    • Summary of the year
  • News
  • Innovation
    • About innovation
    • Information to researchers
    • Information to industry
    • Information to investors
    • The Innovation Award
  • Clinical studies
    • About clinical trials
    • Information to industry
    • Information to study personnel
  • Licensing opportunities
  • Norwegian Bokmål

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Recent Posts

  • Drug Development Project from Oslo Won the Pitch Competition at The Forge
  • 300.000 kroner for best Innovation
  • Oslo University Hospital Selected for Groundbreaking Clinical Study
  • Summary of the year 2024
  • Using AI to Predict Mood Swings

Archives

  • September 2025
  • March 2025
  • January 2025
  • October 2024
  • June 2024
  • January 2024
  • November 2023
  • September 2023
  • March 2023
  • February 2023
  • January 2023
  • April 2022
  • January 2022
  • November 2021
  • October 2020
  • September 2020
  • August 2020

Inven2 AS

Address

Gaustadalléen 21

0349 Oslo

VAT no: 995 495 899

Mailing address

P.O. Box 1061 Blindern

0316 Oslo

Contact us

Employees

post@inven2.com

Practical

About Inven2

Cookies

Terms of Use

Privacy Policy

 

  • Follow
  • Follow
UiO Logo